Central Nervous System Drug Consumption Depending on the Time between Symptom Onset and the Diagnosis of Alzheimer’s Disease: An Analysis by the Registry of Dementias of Girona

2012 ◽  
Vol 33 (2-3) ◽  
pp. 104-110 ◽  
Author(s):  
Laia Calvó-Perxas ◽  
Secundino López-Pousa ◽  
Joan Vilalta-Franch ◽  
Oriol Turró-Garriga ◽  
Michael Blankenburg ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Symptom Onset ◽  
Drug Consumption ◽  
Central Nervous System Drug

scholarly journals Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes

2010 ◽  
Vol 1 (6) ◽  
pp. 420-434 ◽  
Author(s):  
Travis T. Wager ◽  
Ramalakshmi Y. Chandrasekaran ◽  
Xinjun Hou ◽  
Matthew D. Troutman ◽  
Patrick R. Verhoest ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Molecular Properties ◽  
Central Nervous System Drug ◽  
Safety Attributes

scholarly journals Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery

2012 ◽  
Vol 55 (4) ◽  
pp. 1445-1464 ◽  
Author(s):  
Bruce J. Melancon ◽  
Corey R. Hopkins ◽  
Michael R. Wood ◽  
Kyle A. Emmitte ◽  
Colleen M. Niswender ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Drug Discovery ◽  
Allosteric Modulation ◽  
Central Nervous System Drug

Strategies to optimize the brain availability of central nervous system drug candidates

2011 ◽  
Vol 6 (4) ◽  
pp. 371-381 ◽  
Author(s):  
Travis T Wager ◽  
Anabella Villalobos ◽  
Patrick R Verhoest ◽  
Xinjun Hou ◽  
Christopher L Shaffer
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Central Nervous System Drug ◽  
Drug Candidates ◽  
The Brain
Sign in / Sign up

Export Citation Format

Share Document